share_log

HC Wainwright & Co. Maintains Buy on AEON Biopharma, Lowers Price Target to $5

Benzinga ·  Aug 14, 2024 20:15  · Ratings

HC Wainwright & Co. analyst Douglas Tsao maintains AEON Biopharma (AMEX:AEON) with a Buy and lowers the price target from $6 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment